Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
advice, Agency, biotech, camsirubcin, departure, disease, EMA, en, encouraging, endpoint, governed, Grupo, internationally, jaw, lifetime, maximum, Medicinal, package, partial, primary, proportional, pulled, renowned, responding, secondary, sponsor, stable, supplemental, therapy, underscored, variance, warehouse
Removed:
administration, Deferral, disregard, Distinguishing, earlier, eliminate, embedded, escrow, feature, food, half, Hedging, II, Indefinite, indexed, Mandatorily, manufacturer, Noncontrolling, nonemployee, Nonpublic, PFS, progression, Redeemable, Replacement, requesting, round, Seattle, showing, Subtopic
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view